REFLECTION: A Clinical Practice Learning Program for Galleri®

Grail

Status: Enrolling

Conditions: Early Detection of Cancer; Cancer

Treatments: Other: SOC; Other: MCED

Study type: Observational

Funder types: Industry

Identifiers

NCT05205967

GRAIL-MA-001

Details and patient eligibility

About

REFLECTION is a multi-center, prospective, non-interventional, cohort study that will enroll approximately 17,000 individuals who have opted to be screened with Galleri®, a blood-based, multi-cancer early detection (MCED) test in routine clinical settings. The purpose of the study is to understand the real-world experience of Galleri® in clinical settings.

Enrollment: 17,000 estimated patients

Sex: All

Ages: 22+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

Participants are eligible to be included in the study only if all of the following criteria apply:

• Participant has the ability to understand and the willingness to sign a written informed consent form (ICF);
• Participant is at least 22 years old at the time of consent;
• A provider or their designee has ordered the Galleri® test; and
• Participant has the ability to comprehend the participant questionnaires.

Exclusion criteria

• There are no exclusions

Trial design

17,000 participants in 1 patient group

Patients who received the Galleri® test.

Treatment:

Other: MCED

Other: SOC